Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)

HKD 1.16

(0.0%)

Revenue Summary of Dawnrays Pharmaceutical (Holdings) Limited

  • Dawnrays Pharmaceutical (Holdings) Limited's latest annual revenue in 2023 was 1.15 Billion CNY , down -9.9% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited's latest quarterly revenue in 2023 FY was 1.15 Billion CNY , down -9.9% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a annual revenue of 1.27 Billion CNY in annual revenue 2022, up 9.66% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a annual revenue of 1.16 Billion CNY in annual revenue 2021, up 13.75% from previous year.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly revenue of 649.92 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • Dawnrays Pharmaceutical (Holdings) Limited reported a quarterly revenue of 501.22 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Historical Annual Revenue of Dawnrays Pharmaceutical (Holdings) Limited (2023 - 2002)

Year Revenue Revenue Growth
2023 1.15 Billion CNY -9.9%
2022 1.27 Billion CNY 9.66%
2021 1.16 Billion CNY 13.75%
2020 1.02 Billion CNY 7.82%
2019 950 Million CNY 0.11%
2018 948.93 Million CNY 7.53%
2017 882.48 Million CNY 7.05%
2016 824.35 Million CNY -16.31%
2015 985 Million CNY 25.67%
2014 783.8 Million CNY -14.34%
2013 914.97 Million CNY 6.82%
2012 856.53 Million CNY -20.77%
2011 1.08 Billion CNY -15.98%
2010 1.28 Billion CNY 18.91%
2009 1.08 Billion CNY 14.18%
2008 947.71 Million CNY 3.02%
2007 919.94 Million CNY 16.63%
2006 788.79 Million CNY 7.47%
2005 734 Million CNY 25.52%
2004 584.75 Million CNY 19.0%
2003 491.38 Million CNY 49.85%
2002 327.92 Million CNY 0.0%

Peer Revenue Comparison of Dawnrays Pharmaceutical (Holdings) Limited

Name Revenue Revenue Difference
Pak Fah Yeow International Limited 259.15 Million HKD -344.187%
Grand Pharmaceutical Group Limited 10.52 Billion HKD 89.068%
Extrawell Pharmaceutical Holdings Limited 59.09 Million HKD -1847.858%
Wai Yuen Tong Medicine Holdings Limited 783.88 Million HKD -46.852%
Qianhai Health Holdings Limited 961.29 Million HKD -19.75%
Lee's Pharmaceutical Holdings Limited 1.05 Billion HKD -9.317%
Essex Bio-Technology Limited 1.7 Billion HKD 32.546%
Tongfang Kontafarma Holdings Limited 809.1 Million HKD -42.274%
PuraPharm Corporation Limited 406.85 Million HKD -182.935%
SSY Group Limited 6.46 Billion HKD 82.189%
JBM (Healthcare) Limited 648.41 Million HKD -77.532%
Jacobson Pharma Corporation Limited 1.46 Billion HKD 21.573%
China Resources Pharmaceutical Group Limited 270.39 Billion HKD 99.574%